GlaxoSmithKline Responds to Press Release from Senate Committee on Finance About Avandia.

0 Comments | M2 Presswire, May, 2007

M2 PRESSWIRE-22 May 2007-ExplorationInvestor: GlaxoSmithKline Responds to Press Release from Senate Committee on Finance About Avandia(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:22052007 Exploration Investor strives to provide you with outstanding market results. We will be your number one resource for all your small and large cap needs.

While working to keep you in touch with market activity, we also will keep you updated on the latest press. Today we have identified, GlaxoSmithKline (NYSE: GSK) due to the attention they received after this recent corporate developments. The following is GlaxoSmithKline's (NYSE: GSK) response from May 21st to a press release issued by the US Senate Committee on Finance about Avandia (rosiglitazone maleate): The suggestion...

Read the rest of this article with a Free Trial at HighBeam Research.
Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:
  1. You are currently: a Guest |
  4.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)